Abstract
Traceability to a common reference ensures equivalence of results obtained by different assays. Traceability is achieved by an unbroken sequence of calibrations, using reference materials (RMs) that must be commutable. Using non-commutable RMs for calibration will introduce a bias in the calibrated method producing incorrect results for clinical samples (CS). Commutability was defined in 1973 as “the ability of an enzyme material to show inter-assay activity changes comparable to those of the same enzyme in human serum” and later extended as a characteristic of all RMs. However, the concept is still poorly understood and appreciated. Commutability assessment has been covered in CLSI guidelines and requires: (a) selection of 20 CS spanning the relevant concentration range; (b) analysis of both RM and CS with the pair of procedures; (c) data elaboration using regression analysis and calculation if RM fall within the 95% prediction interval defined by CS. This approach has been criticized and to improve it The International Federation of Clinical Chemistry and Laboratory Medicine established a working group that recently finalized recommendations. Commutability is also a requirement for the applicability of external quality assessment (EQA) results in the evaluation of the performance of participating laboratories in terms of standardization of their measurements. Unfortunately, EQA materials are usually not validated for commutability.
Acknowledgments
This paper is dedicated to the memory of Prof. Carlo Franzini (1934–2017), one of the pioneers of the application of commutability concepts in Laboratory Medicine.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Panteghini M. Traceability as a unique tool to improve standardization in laboratory medicine. Clin Biochem 2009;42:236–40.10.1016/j.clinbiochem.2008.09.098Search in Google Scholar
2. Braga F, Panteghini M. Verification of in vitro medical diagnostics (IVD) metrological traceability: responsibilities and strategies. Clin Chim Acta 2014;432:55–61.10.1016/j.cca.2013.11.022Search in Google Scholar
3. Young IS. The enduring importance and challenge of commutability. Clin Chem 2018;64:421–3.10.1373/clinchem.2017.284216Search in Google Scholar
4. Fasce CF Jr, Rej R, Copeland WH, Vanderlinde RE. A discussion of enzyme reference materials: applications and specifications. Clin Chem 1973;19:5–9.10.1093/clinchem/19.1.5Search in Google Scholar
5. Rej R, Jenny RW, Bretaudiere JP. Quality control in clinical chemistry: characterization of reference materials. Talanta 1984;31:851–62.10.1016/0039-9140(84)80214-3Search in Google Scholar
6. JCGM 200:2012. International vocabulary of metrology – basic and general concepts and associated terms (VIM 3), 3rd ed. 2008 version with minor corrections. Sevres, France, 2012.Search in Google Scholar
7. Franzini C, Ceriotti F. Impact of reference materials on accuracy in clinical chemistry. Clin Biochem 1998;31:449–57.10.1016/S0009-9120(98)00054-XSearch in Google Scholar
8. Panteghini M, Ceriotti F, Schumann G, Siekmann L. Establishing a reference system in clinical enzymology. Clin Chem Lab Med 2001;39:795–800.10.1515/CCLM.2001.131Search in Google Scholar PubMed
9. Dati F, Panteghini M, Apple FS, Christenson RH, Mair J, Wu AH. Proposals from the IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): strategies and concepts on standardization of cardiac marker assays. Scand J Clin Lab Invest Suppl 1999;230:113–23.10.1080/00365519909168334Search in Google Scholar
10. Infusino I, Frusciante E, Ferrero CA, Panteghini M. Commutability of two JCTLM-listed secondary reference materials for two commercial lithium assays. Clin Chim Acta 2012;414:152–3.10.1016/j.cca.2012.09.001Search in Google Scholar PubMed
11. Zegers I, Keller T, Schreiber W, Sheldon J, Albertini R, Blirup-Jensen S, et al. Characterization of the new serum protein reference material ERM-DA470k/IFCC: value assignment by immunoassay. Clin Chem 2010;56:1880–8.10.1373/clinchem.2010.148809Search in Google Scholar PubMed
12. Infusino I, Braga F, Valente C, Panteghini M. Commutability of the ERM-DA470k reference material for two assays measuring serum albumin using immunochemical principles. Clin Chem Lab Med 2011;49:1383–4.10.1515/CCLM.2011.619Search in Google Scholar PubMed
13. Braga F, Infusino I, Frusciante E, Ceriotti F, Panteghini M. Trueness evaluation and verification of interassay agreement of 11 serum IgA measuring systems: implications for medical decisions. Clin Chem 2019;65:473–83.10.1373/clinchem.2018.297655Search in Google Scholar PubMed
14. Infusino I, Valente C, Dolci A, Panteghini M. Standardization of ceruloplasmin measurements is still an issue despite the availability of a common reference material. Anal Bioanal Chem 2010;397:521–5.10.1007/s00216-009-3248-0Search in Google Scholar PubMed
15. Zegers I, Beetham R, Keller T, Sheldon J, Bullock D, MacKenzie F, et al. The importance of commutability of reference materials used as calibrators: the example of ceruloplasmin. Clin Chem 2013;59:1322–9.10.1373/clinchem.2012.201954Search in Google Scholar PubMed
16. Thienpont LM, Van Uytfanghe K, Beastall G, Faix JD, Ieiri T, Miller WG, et al. IFCC Working Group on Standardization of Thyroid Function Tests. Report of the IFCC Working Group for Standardization of Thyroid Function Tests; Part 1: Thyroid-stimulating hormone. Clin Chem 2010;56:902–11.10.1373/clinchem.2009.140178Search in Google Scholar PubMed
17. Miller WG, Myers GL, Rej R. Why commutability matters. Clin Chem 2006;52:553–4.10.1373/clinchem.2005.063511Search in Google Scholar PubMed
18. Miller WG, Myers GL. Commutability still matters. Clin Chem 2013;59:1291–3.10.1373/clinchem.2013.208785Search in Google Scholar PubMed
19. ISO 15194:2009. In vitro diagnostic medical devices – measurement of quantities in samples of biological origin – Requirements for certified reference materials and content of supporting documentation. 2nd ed. Geneva, Switzerland: ISO, 2009.Search in Google Scholar
20. ISO 17034:2016. General requirements for the competence of reference material producers. Geneva, Switzerland: ISO, 2016.Search in Google Scholar
21. Panteghini M, Myers GL, Miller GW, Greenberg N. The importance of metrological traceability on the validity of creatinine measurement as an index of renal function. Clin Chem Lab Med 2006;44:1187–92.10.1515/CCLM.2006.234Search in Google Scholar PubMed
22. Deprez L, Toussaint B, Zegers I, Schimmel H, Grote-Koska D, Klauke R, et al. Commutability assessment of candidate reference materials for pancreatic α-amylase. Clin Chem 2018;64:1193–202.10.1373/clinchem.2018.289744Search in Google Scholar PubMed
23. Andreasson U, Kuhlmann J, Pannee J, Umek RM, Stoops E, Vanderstichele H, et al. Commutability of the certified reference materials for the standardization of β-amyloid 1–42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1–40 measurements. Clin Chem Lab Med 2018;56:2058–66.10.1515/cclm-2018-0147Search in Google Scholar PubMed
24. CLSI. Characterization and qualification of commutable reference materials for laboratory medicine; Approved guideline. Document EP30-A (formerly C53-A). Wayne, PA: Clinical and Laboratory Standards Institute, 2010.Search in Google Scholar
25. CLSI. Evaluation of commutability of processed samples: approved guideline – 3rd ed. Document EP14-A3. Wayne, PA: Clinical and Laboratory Standards Institute, 2014.Search in Google Scholar
26. Miller WG, Schimmel H, Rej R, Greenberg N, Ceriotti F, Burns C, et al. for the IFCC Working Group on Commutability. IFCC working group recommendations for assessing commutability. Part 1: General experimental design. Clin Chem 2018;64:447–54.10.1373/clinchem.2017.277525Search in Google Scholar PubMed PubMed Central
27. Nilsson G, Budd JR, Greenberg N, Delatour V, Rej R, Panteghini M, et al. IFCC working group recommendations for assessing commutability. Part 2: Using the difference in bias between a reference material and clinical samples. Clin Chem 2018;64:455–64.10.1373/clinchem.2017.277541Search in Google Scholar PubMed PubMed Central
28. Budd JR, Weykamp C, Rej R, MacKenzie F, Ceriotti F, Greenberg N, et al. for the IFCC Working Group on Commutability. IFCC working group recommendations for assessing commutability. Part 3: Using the calibration effectiveness of a reference material. Clin Chem 2018;64:465–74.10.1373/clinchem.2017.277558Search in Google Scholar PubMed
29. Sandberg S, Fraser CG, Horvath AR, Jansen R, Jones G,Oosterhuis W, et al. Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem Lab Med 2015;53:833–5.10.1515/cclm-2015-0067Search in Google Scholar PubMed
30. Panteghini M. Application of traceability concepts to analytical quality control may reconcile total error with uncertainty of measurement. Clin Chem Lab Med 2010;48:7–10.10.1515/CCLM.2010.020Search in Google Scholar PubMed
31. Braga F, Pasqualetti S, Panteghini M. The role of external quality assessment in the verification of in vitro medical diagnostics in the traceability era. Clin Biochem 2018;57:23–8.10.1016/j.clinbiochem.2018.02.004Search in Google Scholar PubMed
32. Miller WG, Jones GR, Horowitz GL, Weykamp C. Proficiency testing/external quality assessment: current challenges and future directions. Clin Chem 2011;57:1670–80.10.1373/clinchem.2011.168641Search in Google Scholar PubMed
33. CLSI. Preparation and validation of commutable frozen human serum pools as secondary reference materials for cholesterol measurement procedures: approved guideline. Document C37-A. Wayne, PA: Clinical and Laboratory Standards Institute, 1999.Search in Google Scholar
34. James D, Ames D, Lopez B, Still R, Simpson W, Twomey P. External quality assessment: best practice. J Clin Pathol 2014;67:651–5.10.1136/jclinpath-2013-201621Search in Google Scholar PubMed
35. Jones GRD, Albarede S, Kesseler D, MacKenzie F, Mammen J, Pedersen M, et al. EFLM Task Finish Group – Analytical Performance Specifications for EQAS (TFG-APSEQA). Analytical performance specifications for external quality assessment – definitions and descriptions. Clin Chem Lab Med 2017;55:949–55.10.1515/cclm-2017-0151Search in Google Scholar PubMed
36. Stepman HC, Tiikkainen U, Stöckl D, Vesper HW, Edwards SH, Laitinen H, et al. Measurements for 8 common analytes in native sera identify inadequate standardization among 6 routine laboratory assays. Clin Chem 2014;60:855–63.10.1373/clinchem.2013.220376Search in Google Scholar PubMed PubMed Central
37. Weykamp C, Secchiero S, Plebani M, Thelen M, Cobbaert C, Thomas A, et al. Analytical performance of 17 general chemistry analytes across countries and across manufacturers in the INPUtS project of EQA organizers in Italy, the Netherlands, Portugal, United Kingdom and Spain. Clin Chem Lab Med 2017;55:203–11.10.1515/cclm-2016-0220Search in Google Scholar PubMed
38. Kristensen GB, Rustad P, Berg JP, Aakre KM. Analytical bias exceeding desirable quality goal in 4 out of 5 common immunoassays: results of a native single serum sample external quality assessment program for cobalamin, folate, ferritin, thyroid-stimulating hormone, and free T4 analyses. Clin Chem 2016;62:1255–63.10.1373/clinchem.2016.258962Search in Google Scholar PubMed
39. Ferraro S, Braga F, Panteghini M. Laboratory medicine in the new healthcare environment. Clin Chem Lab Med 2016;54:523–33.10.1515/cclm-2015-0803Search in Google Scholar PubMed
40. Braga F, Infusino I, Panteghini M. Performance criteria for combined uncertainty budget in the implementation of metrological traceability. Clin Chem Lab Med 2015;53:905–12.10.1515/cclm-2014-1240Search in Google Scholar PubMed
41. Hage-Sleiman M, Capdevila L, Bailleul S, Lefevre G. High-sensitivity cardiac troponin-I analytical imprecisions evaluated by internal quality control or imprecision profile. Clin Chem Lab Med 2019;57:e49–51.10.1515/cclm-2018-0529Search in Google Scholar PubMed
©2019 Walter de Gruyter GmbH, Berlin/Boston
